Provider-guided programs
Compounded vs FDA-approved peptides: what is the difference?
FDA-approved drugs pass premarket review for safety, effectiveness, and manufacturing quality. Compounded drugs do not — the FDA states they are not reviewed before marketing, and several peptides appear on its list of bulk substances with significant compounding safety risks. The same molecule name can carry very different risk depending on its source.
What FDA approval covers
Approval means clinical trials supported safety and effectiveness for defined indications, and manufacturing meets quality standards with ongoing oversight, adverse-event surveillance, and validated dosing in the label.
What compounding is
Compounding pharmacies prepare medications for individual prescriptions — legitimate and necessary in many situations, but without premarket FDA review. Quality depends on the specific pharmacy, and the FDA has warned about adverse events with some compounded GLP-1 products.
Questions for your provider and pharmacy
- Is this product FDA-approved or compounded?
- If compounded: which pharmacy, what accreditation, and what testing?
- Does this substance appear on the FDA compounding-risk list?
- What adverse events have been reported for this form?
References
- US Food and Drug Administration (2024). FDA's concerns with unapproved GLP-1 drugs used for weight loss. FDA Drug Alerts and Statements. SourceAgency notice
- US Food and Drug Administration (2023). Certain bulk drug substances for use in compounding that may present significant safety risks. FDA Human Drug Compounding. SourceAgency notice
- US Food and Drug Administration (2023). Human drug compounding: compounded drugs are not FDA-approved. FDA. SourceAgency guidance
Found an error? Report a correction.